name,category,termsJanus kinase 2,BBID[10000019$12.IL-6_type_cytok-signal-transduct, 10000069$48.mice_minus_JAKs_and_STATs, 10000096$75.Stats_activators_of_Apoptosis]
Janus kinase 2,BIOCARTA[30000039$h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway, 30000099$h_eponfkbPathway:Erythropoietin mediated neuroprotection through NF-kB, 30000100$h_epoPathway:EPO Signaling Pathway, 30000125$h_ghPathway:Growth Hormone Signaling Pathway, 30000127$h_gleevecpathway:Inhibition of Cellular Proliferation by Gleevec, 30000145$h_ifngPathway:IFN gamma signaling pathway , 30000150$h_IL12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development, 30000157$h_il3Pathway:IL 3 signaling pathway, 30000205$h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells, 30000296$h_tidPathway:Chaperones modulate interferon Signaling Pathway, 30000301$h_TPOPathway:TPO Signaling Pathway]
Janus kinase 2,INTERPRO[450000257$IPR000299:FERM domain, 450000618$IPR000719:Protein kinase, core, 450000852$IPR000980:SH2 motif, 450001096$IPR001245:Tyrosine protein kinase, 450007559$IPR008266:Tyrosine protein kinase, active site, 450008247$IPR009127:Janus kinase, JAK, 450008249$IPR009129:Janus kinase 2, JAK2, 450014575$IPR016251:Tyrosine-protein kinase, Jak/Tyk2, 450015769$IPR017441:Protein kinase, ATP binding site, 450017984$IPR019747:FERM conserved site, 450017986$IPR019749:Band 4.1 domain]
Janus kinase 2,KEGG_PATHWAY[470038831$hsa04062:Chemokine signaling pathway, 470038866$hsa04630:Jak-STAT signaling pathway, 470038886$hsa04920:Adipocytokine signaling pathway]
Janus kinase 2,OMIM_DISEASE[520000707$Budd-Chiari syndrome, 520001992$Genome-wide assocation defines more than 30 distinct susceptibility loci for Crohn's disease, 520002836$Leukemia, acute myelogenous, 520003462$Myelofibrosis, idiopathic, 520003471$Myeloproliferative disorder with erythrocytosis, 520004041$Polycythemia vera, 520004822$Thrombocythemia, essential]
Janus kinase 2,PIR_SUPERFAMILY[630000748$PIRSF000636:tyrosine-protein kinase, Jak/Tyk2 type, 630000749$PIRSF000636:TyrPK_Jak]
Janus kinase 2,SMART[760000192$SM00219:TyrKc, 760000224$SM00252:SH2, 760000266$SM00295:B41]
Janus kinase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000138$atp-binding, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000446$disease mutation, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001304$repeat, 790001397$SH2 domain, 790001547$transferase, 790001586$tyrosine-protein kinase]
Janus kinase 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850067567$chain:Tyrosine-protein kinase JAK2, 850103760$domain:FERM, 850105087$domain:Protein kinase 1, 850105088$domain:Protein kinase 2, 850105349$domain:SH2; atypical, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117925$site:Breakpoint for translocation to form PCM1-JAK2 fusion protein, 850118575$strand, 850118624$turn]
Kruppel-like factor 3 (basic),COG_ONTOLOGY[90000073$General function prediction only]
Kruppel-like factor 3 (basic),SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000811$isopeptide bond, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
Kruppel-like factor 3 (basic),UP_SEQ_FEATURE[850027608$chain:Krueppel-like factor 3, 850102586$compositionally biased region:Pro-rich, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850106258$modified residue, 850114223$region of interest:Repressor domain, 850117294$sequence conflict, 850117295$sequence variant, 850117353$short sequence motif:CTBP-binding motif, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3]
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1,INTERPRO[450000753$IPR000863:Sulfotransferase]
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1,KEGG_PATHWAY[470038774$hsa00534:Heparan sulfate biosynthesis]
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1,PIR_SUPERFAMILY[630012567$PIRSF015800:Caenorhabditis elegans hypothetical protein F08B4.6]
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000624$golgi apparatus, 790000743$hydrolase, 790000775$inflammatory response, 790000919$membrane, 790000993$multifunctional enzyme, 790001409$Signal-anchor, 790001464$sulfotransferase, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein]
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1,UP_SEQ_FEATURE[850000082$active site:For sulfotransferase activity, 850000476$binding site:PAPS, 850007994$chain:Bifunctional heparan sulfate N- deacetylase/N-sulfotransferase 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106259$mutagenesis site, 850106312$nucleotide phosphate-binding region:PAPS, 850111853$region of interest:Heparan sulfate N-deacetylase 1, 850111858$region of interest:Heparan sulfate N-sulfotransferase 1, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region, 850118624$turn]
PDZ domain containing 2,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF]
PDZ domain containing 2,SMART[760000200$SM00228:PDZ]
PDZ domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000356$complete proteome, 790000407$cytoplasm, 790000499$endoplasmic reticulum, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted]
PDZ domain containing 2,UP_SEQ_FEATURE[850036984$chain:PDZ domain-containing protein 2, 850044442$chain:Processed PDZ domain-containing protein 2, 850102597$compositionally biased region:Ser-rich, 850104919$domain:PDZ 1, 850104924$domain:PDZ 2, 850104925$domain:PDZ 3, 850104926$domain:PDZ 4, 850104927$domain:PDZ 5, 850104928$domain:PDZ 6, 850117294$sequence conflict, 850117295$sequence variant, 850118033$site:Cleavage; by caspases, 850118574$splice variant]
PHD finger protein 1,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450002638$IPR002999:Tudor domain, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
PHD finger protein 1,SMART[760000221$SM00249:PHD, 760000302$SM00333:TUDOR]
PHD finger protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
PHD finger protein 1,UP_SEQ_FEATURE[850038131$chain:PHD finger protein 1, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae),COG_ONTOLOGY[90000102$RNA processing and modification]
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae),INTERPRO[450000475$IPR000555:Mov34/MPN/PAD-1, 450011271$IPR012591:Pre-mRNA-processing-splicing factor 8, 450011272$IPR012592:PROCN, 450011660$IPR012984:PRO, C-terminal, 450017817$IPR019580:Pre-mRNA-processing-splicing factor 8, U6-snRNA binding, 450017818$IPR019581:Pre-mRNA-processing-splicing factor 8, U5-snRNA binding, 450017819$IPR019582:RNA recognition motif, spliceosomal PrP8]
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae),KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae),OMIM_DISEASE[520004287$Retinitis pigmentosa-13]
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae),SMART[760000204$SM00232:JAB_MPN]
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001316$retinitis pigmentosa, 790001325$ribonucleoprotein, 790001339$rna-binding, 790001377$sensory transduction, 790001433$Spliceosome, 790001622$vision]
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae),UP_SEQ_FEATURE[850040382$chain:Pre-mRNA-processing-splicing factor 8, 850104794$domain:MPN, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850113181$region of interest:Involved in interaction with pre-mRNA 5' splice site, 850114338$region of interest:Required for interaction with EFTUD2 and SNRNP200, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1,INTERPRO[450000283$IPR000330:SNF2-related, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450009088$IPR010003:HepA-related, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1,OMIM_DISEASE[520004390$Schimke immunoosseous dysplasia]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1,SP_PIR_KEYWORDS[790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000446$disease mutation, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1,UP_SEQ_FEATURE[850063123$chain:SWI/SNF-related matrix-associated actin- dependent regulator of chromatin subfamily A-like protein 1, 850104100$domain:HARP 1, 850104101$domain:HARP 2, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117405$short sequence motif:DESH box]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,BIOCARTA[30000283$h_tall1Pathway:TACI and BCMA stimulation of B cell immune responses.]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,INTERPRO[450005489$IPR006052:Tumor Necrosis Factor, 450008180$IPR008983:Tumour necrosis factor-like]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038874$hsa04672:Intestinal immune network for IgA production]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,PIR_SUPERFAMILY[630030266$PIRSF038812:tumor necrosis factor ligand superfamily member 13]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,SMART[760000180$SM00207:TNF]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000081$angiogenesis, 790000109$Apoptosis, 790000264$cell membrane, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000402$cytokine, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000616$glycoprotein, 790000763$immune response, 790000919$membrane, 790001212$polymorphism, 790001363$Secreted, 790001409$Signal-anchor, 790001555$transmembrane]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,UP_SEQ_FEATURE[850067174$chain:Tumor necrosis factor ligand superfamily member 12, membrane form, 850067175$chain:Tumor necrosis factor ligand superfamily member 12, secreted form, 850067176$chain:Tumor necrosis factor ligand superfamily member 13, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117295$sequence variant, 850117969$site:Cleavage, 850118052$site:Cleavage; by furin, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
butyrophilin-like 8,INTERPRO[450001654$IPR001870:B302 (SPRY)-like, 450003160$IPR003599:Immunoglobulin subtype, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450003406$IPR003879:Butyrophylin-like, 450005994$IPR006574:SPRY-associated, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold, 450016640$IPR018355:SPla/RYanodine receptor subgroup]
butyrophilin-like 8,SMART[760000357$SM00409:IG, 760000394$SM00449:SPRY, 760000524$SM00589:PRY]
butyrophilin-like 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
butyrophilin-like 8,UP_SEQ_FEATURE[850008562$chain:Butyrophilin-like protein 8, 850102883$disulfide bond, 850103078$domain:B30.2/SPRY, 850104408$domain:Ig-like V-type 1, 850104409$domain:Ig-like V-type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 17 open reading frame 55,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 17 open reading frame 55,UP_SEQ_FEATURE[850073379$chain:Uncharacterized protein C17orf55, 850117295$sequence variant]
chromosome 19 open reading frame 40,SP_PIR_KEYWORDS[790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism]
chromosome 19 open reading frame 40,UP_SEQ_FEATURE[850018972$chain:Fanconi anemia-associated protein of 24 kDa, 850114564$region of interest:RuvA domain 2-like, 850117295$sequence variant]
cytohesin 3,BIOCARTA[30000022$h_arapPathway:ADP-Ribosylation Factor]
cytohesin 3,INTERPRO[450000787$IPR000904:SEC7-like, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
cytohesin 3,PIR_SUPERFAMILY[630005444$PIRSF005519:cytohesin]
cytohesin 3,SMART[760000194$SM00222:Sec7, 760000205$SM00233:PH]
cytohesin 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor]
cytohesin 3,UP_SEQ_FEATURE[850013987$chain:Cytohesin-3, 850104979$domain:PH, 850105336$domain:SEC7, 850118574$splice variant]
glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase),COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase),INTERPRO[450001698$IPR001917:Aminotransferase, class-II, pyridoxal-phosphate binding site, 450004318$IPR004839:Aminotransferase, class I and II, 450010184$IPR011282:2-amino-3-ketobutyrate coenzyme A ligase, 450013864$IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1]
glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase),KEGG_PATHWAY[470038746$hsa00260:Glycine, serine and threonine metabolism]
glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase),PIR_SUPERFAMILY[630029671$PIRSF038087:8-amino-7-oxononanoate synthase / 2-amino-3-ketobutyrate:CoA ligase, 630031205$PIRSF800003:alpha-oxoamine synthase]
glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase),SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000356$complete proteome, 790000859$ligase, 790000969$mitochondrion, 790001212$polymorphism, 790001283$pyridoxal phosphate, 790001547$transferase, 790001550$transit peptide]
glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase),UP_SEQ_FEATURE[850001077$chain:2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
interleukin 4 induced 1,BIOCARTA[30000208$h_npcPathway:Mechanism of Protein Import into the Nucleus]
interleukin 4 induced 1,INTERPRO[450001431$IPR001613:Flavin-containing amine oxidase, 450002590$IPR002937:Amine oxidase]
interleukin 4 induced 1,KEGG_PATHWAY[470038745$hsa00250:Alanine, aspartate and glutamate metabolism, 470038747$hsa00270:Cysteine and methionine metabolism, 470038748$hsa00280:Valine, leucine and isoleucine degradation, 470038754$hsa00350:Tyrosine metabolism, 470038755$hsa00360:Phenylalanine metabolism, 470038756$hsa00380:Tryptophan metabolism, 470038757$hsa00400:Phenylalanine, tyrosine and tryptophan biosynthesis]
interleukin 4 induced 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000052$alternative promoter usage, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000537$FAD, 790000559$Flavoprotein, 790000616$glycoprotein, 790000897$lysosome, 790001092$oxidoreductase, 790001212$polymorphism, 790001405$signal]
interleukin 4 induced 1,UP_SEQ_FEATURE[850000341$binding site:FAD, 850000344$binding site:FAD; via amide nitrogen and carbonyl oxygen, 850000555$binding site:Substrate, 850027687$chain:L-amino-acid oxidase, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106285$nucleotide phosphate-binding region:FAD, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
leucine rich repeat containing 27,COG_ONTOLOGY[90000070$Function unknown]
leucine rich repeat containing 27,INTERPRO[450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
leucine rich repeat containing 27,SMART[760000333$SM00369:LRR_TYP]
leucine rich repeat containing 27,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001304$repeat]
leucine rich repeat containing 27,UP_SEQ_FEATURE[850028381$chain:Leucine-rich repeat-containing protein 27, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
major histocompatibility complex, class I, A,BBID[10000091$70.Signal_peptides_(MHC)_class_I_molecules]
major histocompatibility complex, class I, A,BIOCARTA[30000076$h_ctlPathway:CTL mediated immune response against target cells , 30000187$h_mhcPathway:Antigen Processing and Presentation, 30000202$h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity]
major histocompatibility complex, class I, A,INTERPRO[450000912$IPR001039:MHC class I, alpha chain, alpha1 and alpha2, 450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450003158$IPR003597:Immunoglobulin C1-set, 450006486$IPR007110:Immunoglobulin-like, 450009629$IPR010579:MHC class I, alpha chain, C-terminal, 450010088$IPR011161:MHC class I-like antigen recognition, 450012396$IPR013783:Immunoglobulin-like fold]
major histocompatibility complex, class I, A,KEGG_PATHWAY[470038841$hsa04144:Endocytosis, 470038855$hsa04514:Cell adhesion molecules (CAMs), 470038860$hsa04612:Antigen processing and presentation, 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038888$hsa04940:Type I diabetes mellitus, 470038915$hsa05320:Autoimmune thyroid disease, 470038917$hsa05330:Allograft rejection, 470038918$hsa05332:Graft-versus-host disease, 470038923$hsa05416:Viral myocarditis]
major histocompatibility complex, class I, A,OMIM_DISEASE[520000086$Abacavir hypersensitivity, susceptibility to, 520000336$Ankylosing spondylitis, susceptibility to, 1, 520004694$Stevens-Johnson syndrome, susceptibility to]
major histocompatibility complex, class I, A,PIR_SUPERFAMILY[630002127$PIRSF001990:class I histocompatibility antigen]
major histocompatibility complex, class I, A,SMART[760000355$SM00407:IGc1]
major histocompatibility complex, class I, A,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000679$heterodimer, 790000733$host-virus interaction, 790000763$immune response, 790000768$Immunoglobulin domain, 790000919$membrane, 790000924$membrane protein, 790000955$mhc i, 790000956$mhc ii, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal, 790001461$sulfation, 790001555$transmembrane, 790001556$transmembrane protein, 790001557$transplantation antigen, 790001592$ubl conjugation]
major histocompatibility complex, class I, A,UP_SEQ_FEATURE[850024215$chain:HLA class I histocompatibility antigen, A-1 alpha chain, 850024216$chain:HLA class I histocompatibility antigen, A-11 alpha chain, 850024217$chain:HLA class I histocompatibility antigen, A-2 alpha chain, 850024218$chain:HLA class I histocompatibility antigen, A-23 alpha chain, 850024219$chain:HLA class I histocompatibility antigen, A-24 alpha chain, 850024220$chain:HLA class I histocompatibility antigen, A-25 alpha chain, 850024221$chain:HLA class I histocompatibility antigen, A-26 alpha chain, 850024222$chain:HLA class I histocompatibility antigen, A-29 alpha chain, 850024223$chain:HLA class I histocompatibility antigen, A-3 alpha chain, 850024224$chain:HLA class I histocompatibility antigen, A-31 alpha chain, 850024225$chain:HLA class I histocompatibility antigen, A-32 alpha chain, 850024226$chain:HLA class I histocompatibility antigen, A-34 alpha chain, 850024227$chain:HLA class I histocompatibility antigen, A-36 alpha chain, 850024228$chain:HLA class I histocompatibility antigen, A-43 alpha chain, 850024229$chain:HLA class I histocompatibility antigen, A-66 alpha chain, 850024230$chain:HLA class I histocompatibility antigen, A-68 alpha chain, 850024231$chain:HLA class I histocompatibility antigen, A-69 alpha chain, 850024232$chain:HLA class I histocompatibility antigen, A-80 alpha chain, 850031600$chain:MHC class I antigen, 850102883$disulfide bond, 850104352$domain:Ig-like C1-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850110907$region of interest:Alpha-1, 850110908$region of interest:Alpha-2, 850110909$region of interest:Alpha-3, 850111296$region of interest:Connecting peptide, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
microtubule-associated protein 4,INTERPRO[450000949$IPR001084:Tubulin-binding Tau protein]
microtubule-associated protein 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000960$microtubule, 790000961$microtubule binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001484$tandem repeat]
microtubule-associated protein 4,UP_SEQ_FEATURE[850031690$chain:Microtubule-associated protein 4, 850106258$modified residue, 850106259$mutagenesis site, 850109921$region of interest:17 X 14 AA tandem repeats, 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115216$repeat:16, 850115231$repeat:17, 850115273$repeat:2, 850115405$repeat:26 residues 1, 850115406$repeat:26 residues 2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115585$repeat:8; truncated, 850115588$repeat:9, 850117081$repeat:Tau/MAP 1, 850117082$repeat:Tau/MAP 2, 850117083$repeat:Tau/MAP 3, 850117084$repeat:Tau/MAP 4, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
microtubule-associated protein 7,INTERPRO[450007865$IPR008604:E-MAP-115]
microtubule-associated protein 7,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790000960$microtubule, 790000961$microtubule binding, 790001162$phosphoprotein, 790001212$polymorphism]
microtubule-associated protein 7,UP_SEQ_FEATURE[850017514$chain:Ensconsin, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
mitogen-activated protein kinase kinase kinase kinase 5,BIOCARTA[30000001$h_41bbPathway:The 4-1BB-dependent immune response, 30000180$h_mapkPathway:MAPKinase Signaling Pathway]
mitogen-activated protein kinase kinase kinase kinase 5,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001035$IPR001180:Citron-like, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
mitogen-activated protein kinase kinase kinase kinase 5,PIR_SUPERFAMILY[630029790$PIRSF038172:mitogen-activated protein kinase kinase kinase kinase, 630030910$PIRSF500750:mitogen-activated protein kinase kinase kinase kinase 5]
mitogen-activated protein kinase kinase kinase kinase 5,SMART[760000028$SM00036:CNH, 760000193$SM00220:S_TKc]
mitogen-activated protein kinase kinase kinase kinase 5,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
mitogen-activated protein kinase kinase kinase kinase 5,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850032128$chain:Mitogen-activated protein kinase kinase kinase kinase 5, 850103376$domain:CNH, 850105086$domain:Protein kinase, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant]
myosin phosphatase Rho interacting protein; similar to Myosin phosphatase Rho-interacting protein (Rho-interacting protein 3) (M-RIP) (RIP3) (p116Rip),INTERPRO[450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
myosin phosphatase Rho interacting protein; similar to Myosin phosphatase Rho-interacting protein (Rho-interacting protein 3) (M-RIP) (RIP3) (p116Rip),SMART[760000205$SM00233:PH]
myosin phosphatase Rho interacting protein; similar to Myosin phosphatase Rho-interacting protein (Rho-interacting protein 3) (M-RIP) (RIP3) (p116Rip),SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
myosin phosphatase Rho interacting protein; similar to Myosin phosphatase Rho-interacting protein (Rho-interacting protein 3) (M-RIP) (RIP3) (p116Rip),UP_SEQ_FEATURE[850033006$chain:Myosin phosphatase Rho-interacting protein, 850102597$compositionally biased region:Ser-rich, 850104980$domain:PH 1, 850104981$domain:PH 2, 850106258$modified residue, 850112314$region of interest:Interaction with F-actin, 850112700$region of interest:Interaction with PPP1R12A, 850112779$region of interest:Interaction with RHOA, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
neurexophilin 3,INTERPRO[450009512$IPR010450:Neurexophilin]
neurexophilin 3,PIR_SUPERFAMILY[630029601$PIRSF038019:neurexophilin]
neurexophilin 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
neurexophilin 3,UP_SEQ_FEATURE[850033927$chain:Neurexophilin-3, 850105770$glycosylation site:N-linked (GlcNAc...), 850111960$region of interest:II, 850111967$region of interest:III, 850113227$region of interest:IV (linker domain), 850115036$region of interest:V (Cys-rich), 850117294$sequence conflict, 850117814$signal peptide]
proprotein convertase subtilisin/kexin type 6,INTERPRO[450000180$IPR000209:Peptidase S8 and S53, subtilisin, kexin, sedolisin, 450002550$IPR002884:Proprotein convertase, P, 450005638$IPR006212:Furin-like repeat, 450006475$IPR007087:Zinc finger, C2H2-type, 450009938$IPR010909:PLAC, 450013941$IPR015500:Peptidase S8, subtilisin-related]
proprotein convertase subtilisin/kexin type 6,SMART[760000233$SM00261:FU]
proprotein convertase subtilisin/kexin type 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001383$Serine protease, 790001405$signal, 790001652$zymogen]
proprotein convertase subtilisin/kexin type 6,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850044694$chain:Proprotein convertase subtilisin/kexin type 6, 850104144$domain:Homo B/P, 850105021$domain:PLAC, 850105770$glycosylation site:N-linked (GlcNAc...), 850111190$region of interest:Catalytic, 850111347$region of interest:CRM (Cys-rich motif), 850117294$sequence conflict, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide, 850118006$site:Cleavage; by autolysis, 850118574$splice variant]
transcription factor binding to IGHM enhancer 3,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450010429$IPR011598:Helix-loop-helix DNA-binding]
transcription factor binding to IGHM enhancer 3,OMIM_DISEASE[520004228$Renal cell carcinoma, papillary, 1]
transcription factor binding to IGHM enhancer 3,SMART[760000321$SM00353:HLH]
transcription factor binding to IGHM enhancer 3,SP_PIR_KEYWORDS[790000020$activator, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000763$immune response, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation, 790001592$ubl conjugation]
transcription factor binding to IGHM enhancer 3,UP_SEQ_FEATURE[850065156$chain:Transcription factor E3, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850104712$domain:Leucine-zipper, 850106258$modified residue, 850114706$region of interest:Strong transcription activation domain, 850117294$sequence conflict, 850117295$sequence variant, 850117859$site:Breakpoint for translocation to form ASPSCR1-TFE3 oncogene, 850117917$site:Breakpoint for translocation to form NONO-TFE3, PSF-TFE3 and ASPSCR1-TFE3 oncogenes, 850117932$site:Breakpoint for translocation to form PRCC-TFE3 oncogene]
wingless-type MMTV integration site family, member 3,INTERPRO[450005264$IPR005816:Secreted growth factor Wnt protein, 450005265$IPR005817:Wnt superfamily, 450008261$IPR009141:Wnt-3 protein, 450016453$IPR018161:Secreted growth factor Wnt protein, conserved site]
wingless-type MMTV integration site family, member 3,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038849$hsa04340:Hedgehog signaling pathway, 470038885$hsa04916:Melanogenesis, 470038899$hsa05200:Pathways in cancer, 470038907$hsa05217:Basal cell carcinoma]
wingless-type MMTV integration site family, member 3,OMIM_DISEASE[520004806$Tetra-amelia, autosomal recessive]
wingless-type MMTV integration site family, member 3,PIR_SUPERFAMILY[630001927$PIRSF001784:int-1 transforming protein]
wingless-type MMTV integration site family, member 3,SMART[760000085$SM00097:WNT1]
wingless-type MMTV integration site family, member 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000530$extracellular matrix, 790000616$glycoprotein, 790001271$Proto-oncogene, 790001363$Secreted, 790001405$signal, 790001642$wnt signaling pathway]
wingless-type MMTV integration site family, member 3,UP_SEQ_FEATURE[850048672$chain:Proto-oncogene protein Wnt-3, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide]
zinc finger protein 420,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 420,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 420,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 420,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 420,UP_SEQ_FEATURE[850101638$chain:Zinc finger protein 420, 850104552$domain:KRAB, 850106258$modified residue, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118666$zinc finger region:C2H2-type 13, 850118669$zinc finger region:C2H2-type 14, 850118671$zinc finger region:C2H2-type 15, 850118674$zinc finger region:C2H2-type 16, 850118676$zinc finger region:C2H2-type 17, 850118679$zinc finger region:C2H2-type 18, 850118682$zinc finger region:C2H2-type 19, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
